Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was later reported that the patient's pain is likely in the neck area, but it is unclear as the patient is non-verbal.The physician attributes the cause of the pain to the patient's infection, and intervention was taken for both patient comfort and to preclude serious injury.The infection is located at both the left nuchal area and left generator area.The physician notes the cause of infection is unclear but they suspect that the patient may have been bothered by vns presence.The patient has not been diagnosed with tachycardia or any cardiac issues.
|